Cortexyme () EV/EBITDA US GAAP (year values) |
||||||||
2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | |||
EV/EBITDA | ? | 0.02 | 6.25 | -24.8 | -8.58 | -2.98 | -861.6 | |
Changes by years, y/y, % | +38 247% | -496% | -65% | -65% |
Cortexyme. EV/EBITDA
Cortexyme. EV/EBITDA, changes, %
Cortexyme () EV/EBITDA US GAAP (quarter values) |
||||||||
2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
EV/EBITDA | ? | -16.9 | -30.7 | -2.99 | -1.07 | -861.6 | -861.6 | |
Changes by years, y/y, % | -18% | +62% | -67% | -90% | +5 010% | |||
Changes by quarters, q/q, % | +50% | +82% | -90% | -64% | +80 387% |